Evommune, Inc. reports stock option adjustments by director David E. Cohen, reflecting strategic moves in the pharmaceutical industry.
| Name | Evommune, Inc. |
|---|---|
| CIK | 0002044725 |
| Tickers | EVMN |
| Exchanges | NYSE |
| Entity type | operating |
| Category | <br>Emerging growth company |
| SIC | 2834 Pharmaceutical Preparations |
| EIN | 850742575 |
| LEI | — |
| Fiscal year end | 1231 |
| State of incorporation | DE DE |
| Phone | (650) 223-7745 |
| Website | — |
| Investor website | — |
| Owner org | 03 Life Sciences |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 1 |
| Insider transactions (owner) | 0 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
Evommune, Inc. reports stock option adjustments by director David E. Cohen, reflecting strategic moves in the pharmaceutical industry.
Evommune, Inc. disclosed stock option transactions that may impact executive compensation and share structure, reflecting industry trends in the pharmaceutical sector.
Evommune, Inc. reports stock option transactions for CEO Luis C. Pena, reflecting strategic adjustments in executive compensation.
Evommune, Inc. has repriced stock options for its Chief Medical Officer, Eugene Bauer, reflecting strategic changes in the pharmaceutical industry.
Evommune, Inc. announces stock option repricing for Chief Business & Legal Officer Gregory S. Moss, reflecting adjustments in executive compensation strategies.
Evommune's CFO Kyle Carver has reported significant stock option transactions, reflecting strategic compensation adjustments in the pharmaceutical industry.
Evommune, Inc. reports a dilution in beneficial ownership by RA Capital Management, indicating a shift in shareholder dynamics in the pharmaceutical sector.
Evommune, Inc. reveals a live webcast about its product EVO570, showcasing its commitment to transparency in the pharmaceutical preparations sector.
Evommune, Inc. has filed a prospectus supplement to update its registration statement, highlighting ongoing capital-raising efforts.
Evommune, Inc. signs a $20 million licensing deal with Hinova Pharmaceuticals for VAV1 degraders, expanding its pharmaceutical product portfolio.
155 filing rows loaded from submissions recent.
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-17 | 4 | PRIMARY DOCUMENT | 0001290976-26-000006 | 13908 | ||||||
| 2026-11-17 | 4 | PRIMARY DOCUMENT | 0001347383-26-000005 | 13761 | ||||||
| 2026-11-17 | 4 | PRIMARY DOCUMENT | 0001216994-26-000005 | 13777 | ||||||
| 2026-11-17 | 4 | PRIMARY DOCUMENT | 0002091053-26-000007 | 14088 | ||||||
| 2026-11-17 | 4 | PRIMARY DOCUMENT | 0002092017-26-000009 | 14100 | ||||||
| 2026-11-17 | 4 | PRIMARY DOCUMENT | 0001757072-26-000009 | 14062 | ||||||
| 2026-11-17 | 4 | PRIMARY DOCUMENT | 0001742496-26-000007 | 14080 | ||||||
| 2026-11-17 | 4 | PRIMARY DOCUMENT | 0001678620-26-000005 | 14076 | ||||||
| 2026-11-17 | 4 | PRIMARY DOCUMENT | 0001620548-26-000011 | 14097 | ||||||
| 2026-11-17 | 424B3 | 424B3 | 0001193125-26-465623 | 333-295140 | 261566765 | 33 | 101777 | |||
| 2026-11-17 | 8-K | 8-K | 5.02 | 0001193125-26-465600 | 001-42938 | 261566585 | 34 | 181601 | 1 | 1 |
| 2026-11-16 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000919574-26-008112 | 005-95351 | 261560842 | 34 | 12210 | |||
| 2026-11-16 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000080255-26-000727 | 005-95351 | 261556472 | 34 | 7638 | |||
| 2026-11-12 | 424B3 | 424B3 | 0001193125-26-458509 | 333-295140 | 261547397 | 33 | 2089878 | |||
| 2026-11-12 | 10-Q | 10-Q | 0001193125-26-458385 | 001-42938 | 261547034 | 34 | 10474626 | 1 | 1 | |
| 2026-11-12 | 8-K | 8-K | 2.02,7.01,9.01 | 0001193125-26-458329 | 001-42938 | 261546865 | 34 | 31667976 | 1 | 1 |
| 2026-11-10 | SCHEDULE 13D/A | xslSCHEDULE_13D_X02/primary_doc.xml | 0001346824-26-000259 | 005-95351 | 261541198 | 34 | 15319 | |||
| 2026-11-05 | 8-K | 8-K | 7.01,9.01 | 0001193125-26-448443 | 001-42938 | 261524591 | 34 | 1067165 | 1 | 1 |
| 2026-11-04 | 424B3 | 424B3 | 0001193125-26-447627 | 333-295140 | 261523757 | 33 | 123696 | |||
| 2026-11-04 | 8-K | 8-K | 1.01,3.02,7.01,8.01 | 0001193125-26-447608 | 001-42938 | 261523690 | 34 | 12676235 | 1 | 1 |
| 2026-10-15 | 4 | PRIMARY DOCUMENT | 0001620548-26-000009 | 5280 | ||||||
| 2026-10-01 | 8-K | 8-K | 7.01,9.01 | 0001193125-26-409865 | 001-42938 | 261428981 | 34 | 1090597 | 1 | 1 |
| 2026-09-23 | 8-K | 8-K | 7.01,9.01 | 0001193125-26-399378 | 001-42938 | 261401082 | 34 | 1080128 | 1 | 1 |
| 2026-09-15 | 8-K | 8-K | 7.01,9.01 | 0001193125-26-391390 | 001-42938 | 261379194 | 34 | 18754768 | 1 | 1 |
| 2026-09-09 | 424B3 | 424B3 | 0001193125-26-385431 | 333-295140 | 261366119 | 33 | 95868 | |||
| 2026-09-09 | 8-K | 8-K | 7.01,8.01,9.01 | 0001193125-26-385430 | 001-42938 | 261366114 | 34 | 1083320 | 1 | 1 |
| 2026-08-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001757283-26-000018 | 005-95351 | 261282054 | 34 | 13001 | |||
| 2026-08-14 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0000080255-26-000581 | 005-95351 | 261277457 | 34 | 7434 | |||
| 2026-08-06 | 424B3 | 424B3 | 0001193125-26-338017 | 333-295140 | 261249091 | 33 | 2044835 | |||
| 2026-08-06 | 10-Q | 10-Q | 0001193125-26-337984 | 001-42938 | 261249022 | 34 | 9987548 | 1 | 1 | |
| 2026-08-06 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-337964 | 001-42938 | 261248893 | 34 | 1256405 | 1 | 1 |
| 2026-07-30 | 8-K | 8-K | 7.01,9.01 | 0001193125-26-324972 | 001-42938 | 261220280 | 34 | 1079507 | 1 | 1 |
| 2026-07-16 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0000919574-26-004453 | 005-95351 | 261181089 | 34 | 17194 | |||
| 2026-07-10 | 4 | PRIMARY DOCUMENT | 0001757072-26-000007 | 5250 | ||||||
| 2026-07-08 | 4 | PRIMARY DOCUMENT | 0001290976-26-000004 | 5804 | ||||||
| 2026-06-29 | 424B3 | 424B3 | 0001193125-26-286924 | 333-295140 | 261131472 | 33 | 93010 | |||
| 2026-06-29 | 8-K | 8-K | 7.01,8.01,9.01 | 0001193125-26-286918 | 001-42938 | 261131468 | 34 | 1082840 | 1 | 1 |
| 2026-06-24 | 4 | PRIMARY DOCUMENT | 0002091053-26-000005 | 13238 | ||||||
| 2026-06-24 | 4 | PRIMARY DOCUMENT | 0002092017-26-000007 | 9009 | ||||||
| 2026-06-24 | 4 | PRIMARY DOCUMENT | 0001620548-26-000007 | 5466 | ||||||
| 2026-06-22 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-006381 | 001-42938 | 261107732 | 33 | 4872 | |||
| 2026-06-03 | 4 | PRIMARY DOCUMENT | 0001216994-26-000003 | 5667 | ||||||
| 2026-06-03 | 4 | PRIMARY DOCUMENT | 0001290976-26-000002 | 5798 | ||||||
| 2026-06-03 | 4 | PRIMARY DOCUMENT | 0001347383-26-000003 | 9916 | ||||||
| 2026-06-03 | 4 | PRIMARY DOCUMENT | 0002092017-26-000005 | 9543 | ||||||
| 2026-06-03 | 4 | PRIMARY DOCUMENT | 0001620548-26-000005 | 5467 | ||||||
| 2026-06-02 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-005513 | 001-42938 | 261056805 | 33 | 5381 | |||
| 2026-06-02 | 424B3 | 424B3 | 0001193125-26-253489 | 333-295140 | 261056010 | 33 | 94684 | |||
| 2026-06-02 | 8-K | 8-K | 5.07 | 0001193125-26-253482 | 001-42938 | 261055977 | 34 | 173019 | 1 | 1 |
| 2026-06-01 | 4 | PRIMARY DOCUMENT | 0001742496-26-000005 | 10513 | ||||||
| 2026-06-01 | 4 | PRIMARY DOCUMENT | 0001757072-26-000005 | 9505 | ||||||
| 2026-06-01 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-005432 | 001-42938 | 261051845 | 33 | 5323 | |||
| 2026-06-01 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-005430 | 001-42938 | 261051835 | 33 | 5480 | |||
| 2026-05-28 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-005228 | 001-42938 | 261036885 | 33 | 4635 | |||
| 2026-05-28 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-005227 | 001-42938 | 261036881 | 33 | 5442 | |||
| 2026-05-07 | 424B3 | 424B3 | 0001193125-26-212038 | 333-295140 | 26953697 | 33 | 1590588 | |||
| 2026-05-07 | 10-Q | 10-Q | 0001193125-26-211963 | 001-42938 | 26953598 | 34 | 8876425 | 1 | 1 | |
| 2026-05-07 | 8-K | 8-K | 2.02,7.01 | 0001193125-26-211934 | 001-42938 | 26953432 | 34 | 29207448 | 1 | 1 |
| 2026-04-24 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-26-001330 | 333-295140 | 26896317 | 33 | 1659 | ||
| 2026-04-24 | 424B3 | 424B3 | 0001193125-26-177356 | 333-295140 | 26894476 | 33 | 756996 | |||
| 2026-04-22 | CORRESP | filename1.htm | 0001193125-26-170867 | 7028 | ||||||
| 2026-04-22 | UPLOAD | filename1.pdf | 0000000000-26-004089 | 333-295140 | 147868 | |||||
| 2026-04-21 | ARS | ARS | 0001193125-26-166761 | 001-42938 | 26879460 | 34 | 5004533 | |||
| 2026-04-21 | DEFA14A | DEFA14A | 0001193125-26-166755 | 001-42938 | 26879447 | 34 | 2101701 | 1 | 1 | |
| 2026-04-21 | DEF 14A | DEF 14A | 0001193125-26-166747 | 001-42938 | 26879421 | 34 | 2736630 | 1 | 1 | |
| 2026-04-17 | 4 | PRIMARY DOCUMENT | 0002092017-26-000003 | 5764 | ||||||
| 2026-04-17 | 4 | PRIMARY DOCUMENT | 0002091053-26-000003 | 5752 | ||||||
| 2026-04-17 | 4 | PRIMARY DOCUMENT | 0001678620-26-000003 | 5760 | ||||||
| 2026-04-17 | 4 | PRIMARY DOCUMENT | 0001757072-26-000003 | 5726 | ||||||
| 2026-04-17 | 4 | PRIMARY DOCUMENT | 0001742496-26-000003 | 5742 | ||||||
| 2026-04-17 | 4 | PRIMARY DOCUMENT | 0001620548-26-000003 | 5759 | ||||||
| 2026-04-17 | S-1 | S-1 | 0001193125-26-161516 | 333-295140 | 26871545 | 33 | 1007041 | 1 | 1 | |
| 2026-04-13 | 8-K | 8-K | 7.01,9.01 | 0001193125-26-152864 | 001-42938 | 26857899 | 34 | 16316788 | 1 | 1 |
| 2026-03-05 | S-8 | S-8 | 0001193125-26-093978 | 333-294045 | 26726292 | 33 | 645087 | 1 | 1 | |
| 2026-03-05 | 10-K | 10-K | 0001193125-26-093932 | 001-42938 | 26726149 | 34 | 27174798 | 1 | 1 | |
| 2026-03-05 | 8-K | 8-K | 2.02 | 0001193125-26-093920 | 001-42938 | 26726104 | 34 | 23518496 | 1 | 1 |
| 2026-02-19 | SCHEDULE 13D/A | xslSCHEDULE_13D_X01/primary_doc.xml | 0001193125-26-059504 | 005-95351 | 26654903 | 34 | 12592 | |||
| 2026-02-19 | 4 | 4 | 0001193125-26-059500 | 5691 | ||||||
| 2026-02-18 | 4 | xslF345X05/form4-02192026_020236.xml | 0002094941-26-000002 | 5103 | ||||||
| 2026-02-17 | SCHEDULE 13D/A | xslSCHEDULE_13D_X01/primary_doc.xml | 0001346824-26-000063 | 005-95351 | 26644619 | 34 | 17689 | |||
| 2026-02-17 | 4 | xslF345X05/form4-02182026_120251.xml | 0001231919-26-000164 | 13323 | ||||||
| 2026-02-13 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001012975-26-000142 | 005-95351 | 26632842 | 34 | 108498 | |||
| 2026-02-13 | 8-K | 8-K | 1.01,3.02,7.01,9.01 | 0001193125-26-049888 | 001-42938 | 26628955 | 34 | 1684509 | 1 | 1 |
| 2026-02-10 | 8-K | 8-K | 7.01,9.01 | 0001193125-26-043771 | 001-42938 | 26613541 | 34 | 13373053 | 1 | 1 |
| 2025-12-22 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001012975-25-000937 | 9175 | ||||||
| 2025-12-19 | 4 | PRIMARY DOCUMENT | 0001678620-25-000013 | 5645 | ||||||
| 2025-12-11 | 4 | PRIMARY DOCUMENT | 0001620548-25-000011 | 4879 | ||||||
| 2025-12-11 | 4 | PRIMARY DOCUMENT | 0002092017-25-000009 | 4885 | ||||||
| 2025-12-11 | 4 | PRIMARY DOCUMENT | 0001742496-25-000012 | 5856 | ||||||
| 2025-12-11 | 4 | PRIMARY DOCUMENT | 0002091053-25-000009 | 4864 | ||||||
| 2025-12-11 | 4 | PRIMARY DOCUMENT | 0001757072-25-000010 | 4848 | ||||||
| 2025-12-11 | 4 | PRIMARY DOCUMENT | 0001678620-25-000011 | 4882 | ||||||
| 2025-12-11 | 10-Q | 10-Q | 0001193125-25-315972 | 001-42938 | 251565177 | 34 | 11577058 | 1 | 1 | |
| 2025-12-11 | 8-K | 8-K | 2.02,9.01 | 0001193125-25-315918 | 001-42938 | 251565026 | 34 | 1266953 | 1 | 1 |
| 2025-11-17 | SCHEDULE 13D | xslSCHEDULE_13D_X01/primary_doc.xml | 0001346824-25-000063 | 005-95351 | 251491593 | 34 | 27208 | |||
| 2025-11-17 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001757283-25-000005 | 005-95351 | 251491467 | 34 | 15841 | |||
| 2025-11-14 | SCHEDULE 13D | xslSCHEDULE_13D_X01/primary_doc.xml | 0001193125-25-283141 | 005-95351 | 251487138 | 34 | 429252 | |||
| 2025-11-12 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001012975-25-000730 | 35827 | ||||||
| 2025-11-12 | 4 | xslF345X05/form4-11122025_091126.xml | 0001346824-25-000049 | 16100 | ||||||
| 2025-11-12 | 4 | xslF345X05/form4-11122025_091112.xml | 0001876264-25-000006 | 14099 | ||||||
| 2025-11-12 | 4 | xslF345X05/form4-11122025_091104.xml | 0002094941-25-000004 | 14119 | ||||||
| 2025-11-12 | 4 | xslF345X05/form4-11122025_091154.xml | 0001620548-25-000009 | 6938 | ||||||
| 2025-11-12 | 4 | xslF345X05/form4-11122025_091148.xml | 0002092017-25-000007 | 6937 | ||||||
| 2025-11-12 | 4 | xslF345X05/form4-11122025_091142.xml | 0001742496-25-000010 | 7954 | ||||||
| 2025-11-12 | 4 | xslF345X05/form4-11122025_091138.xml | 0001551966-25-000007 | 34910 | ||||||
| 2025-11-12 | 4 | xslF345X05/form4-11122025_091133.xml | 0002091053-25-000007 | 6916 | ||||||
| 2025-11-12 | 4 | xslF345X05/form4-11122025_091132.xml | 0001347383-25-000009 | 6883 | ||||||
| 2025-11-12 | 4 | xslF345X05/form4-11122025_091140.xml | 0001757072-25-000008 | 6899 | ||||||
| 2025-11-12 | 4 | xslF345X05/form4-11122025_091121.xml | 0001678620-25-000009 | 9379 | ||||||
| 2025-11-07 | S-8 | S-8 | 0001193125-25-272519 | 333-291386 | 251463361 | 33 | 416304 | 1 | 1 | |
| 2025-11-07 | 4 | xslF345X05/form4-11072025_041114.xml | 0001347383-25-000007 | 5441 | ||||||
| 2025-11-07 | 4 | xslF345X05/form4-11072025_041112.xml | 0001290976-25-000010 | 5685 | ||||||
| 2025-11-07 | 4 | xslF345X05/form4-11072025_041110.xml | 0001216994-25-000008 | 5457 | ||||||
| 2025-11-07 | 4 | xslF345X05/form4-11072025_041109.xml | 0002092017-25-000005 | 5512 | ||||||
| 2025-11-07 | 4 | xslF345X05/form4-11072025_041107.xml | 0002091053-25-000005 | 5491 | ||||||
| 2025-11-07 | 4 | xslF345X05/form4-11072025_041105.xml | 0001757072-25-000006 | 5474 | ||||||
| 2025-11-07 | 4 | xslF345X05/form4-11072025_041102.xml | 0001620548-25-000007 | 5504 | ||||||
| 2025-11-07 | 4 | xslF345X05/form4-11072025_041104.xml | 0001742496-25-000008 | 5487 | ||||||
| 2025-11-07 | 8-K | 8-K | 5.03,9.01 | 0001193125-25-272282 | 001-42938 | 251462462 | 34 | 182138 | 1 | 1 |
| 2025-11-06 | 424B4 | 424B4 | 0001193125-25-270066 | 333-290793 | 251459468 | 33 | 11011767 | |||
| 2025-11-06 | FWP | FWP | 0001193125-25-267581 | 333-290793 | 251455666 | 34 | 11494 | |||
| 2025-11-05 | 3 | xslF345X02/form3-11062025_011125.xml | 0001231919-25-000435 | 13705 | ||||||
| 2025-11-05 | 3 | xslF345X02/form3-11062025_011108.xml | 0001876264-25-000004 | 8024 | ||||||
| 2025-11-05 | 3 | INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES | 0001012975-25-000705 | 21705 | ||||||
| 2025-11-05 | 3 | xslF345X02/form3-11062025_011156.xml | 0002094941-25-000002 | 14265 | ||||||
| 2025-11-05 | 3 | xslF345X02/form3-11062025_011101.xml | 0001620548-25-000005 | 21006 | ||||||
| 2025-11-05 | 3 | xslF345X02/form3-11062025_011115.xml | 0002092017-25-000003 | 19073 | ||||||
| 2025-11-05 | 3 | xslF345X02/form3-11062025_011119.xml | 0001742496-25-000006 | 20805 | ||||||
| 2025-11-05 | 3 | xslF345X02/form3-11062025_011126.xml | 0001216994-25-000006 | 16197 | ||||||
| 2025-11-05 | 3 | xslF345X02/form3-11062025_011138.xml | 0001290976-25-000008 | 9453 | ||||||
| 2025-11-05 | 3 | xslF345X02/form3-11062025_011144.xml | 0001551966-25-000005 | 24716 | ||||||
| 2025-11-05 | 3 | xslF345X02/form3-11062025_011152.xml | 0002091053-25-000003 | 21348 | ||||||
| 2025-11-05 | 3 | xslF345X02/form3-11062025_011155.xml | 0001792061-25-000003 | 9291 | ||||||
| 2025-11-05 | 3 | xslF345X02/form3-11062025_011151.xml | 0001347383-25-000005 | 17111 | ||||||
| 2025-11-05 | 3 | xslF345X02/form3-11062025_011111.xml | 0001757072-25-000004 | 19047 | ||||||
| 2025-11-05 | 3 | xslF345X02/form3-11062025_121116.xml | 0001678620-25-000007 | 20450 | ||||||
| 2025-11-05 | CERT | NYSE CERTIFICATION | 0000876661-25-000841 | 001-42938 | 251452010 | 34 | 164565 | |||
| 2025-11-04 | 8-A12B | 8-A12B | 0001193125-25-264660 | 001-42938 | 251448915 | 34 | 14606 | |||
| 2025-10-30 | FWP | FWP | 0001193125-25-257360 | 333-290793 | 251432094 | 34 | 10971 | |||
| 2025-10-17 | S-1/A | S-1/A | 0001193125-25-242492 | 333-290793 | 251400868 | 33 | 11814381 | 1 | 1 | |
| 2025-10-09 | S-1 | S-1 | 0001193125-25-235673 | 333-290793 | 251384547 | 33 | 15938213 | 1 | 1 | |
| 2025-09-23 | DRS/A | filename1.htm | 0001193125-25-211895 | 377-08010 | 251331520 | 33 | 11216430 | |||
| 2025-09-22 | DRSLTR | filename1.htm | 0001193125-25-211922 | 28664 | ||||||
| 2025-09-10 | UPLOAD | filename1.pdf | 0000000000-25-009825 | 377-08010 | 46546 | |||||
| 2025-09-02 | DRS/A | filename1.htm | 0000950123-25-008631 | 377-08010 | 251282582 | 33 | 10290910 | |||
| 2025-08-29 | DRSLTR | filename1.htm | 0000950123-25-008632 | 40521 | ||||||
| 2025-07-30 | UPLOAD | filename1.pdf | 0000000000-25-008014 | 377-08010 | 48506 | |||||
| 2025-07-18 | DRSLTR | filename1.htm | 0000950123-25-006473 | 65567 | ||||||
| 2025-07-18 | DRS/A | filename1.htm | 0000950123-25-006472 | 377-08010 | 251134954 | 33 | 12643239 | |||
| 2025-06-10 | UPLOAD | filename1.pdf | 0000000000-25-006098 | 377-08010 | 59089 | |||||
| 2025-05-14 | DRS | filename1.htm | 0000950123-25-005244 | 377-08010 | 25946312 | 33 | 5699584 | |||
| 2025-01-08 | D | xslFormDX01/primary_doc.xml | 06b | 0002044725-25-000004 | 021-534546 | 25517241 | 33 | 15670 | ||
| 2025-01-08 | D | xslFormDX01/primary_doc.xml | 06b | 0002044725-25-000003 | 021-534516 | 25516204 | 33 | 15668 | ||
| 2025-01-08 | D | xslFormDX01/primary_doc.xml | 06b | 0002044725-25-000002 | 021-534510 | 25516104 | 33 | 15675 | ||
| 2025-01-07 | D | xslFormDX01/primary_doc.xml | 06b | 0002044725-25-000001 | 021-534380 | 25512798 | 33 | 15669 |
One latest value per concept from companyfacts (223 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| dei | EntityCommonStockSharesOutstanding | Entity Common Stock, Shares Outstanding | shares | 41.35M | 2026-11-10 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 | |
| dei | EntityPublicFloat | Entity Public Float | USD | 0 | 2025-06-30 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-093932 | |
| ffd | NetFeeAmt | NetFeeAmt | USD | 16,230.26 | 2026-04-14 | S-1 | 2026-04-17 | 0001193125-26-161516 | |||
| ffd | TtlFeeAmt | TtlFeeAmt | USD | 16,230.26 | 2026-04-14 | S-1 | 2026-04-17 | 0001193125-26-161516 | |||
| ffd | TtlOfferingAmt | TtlOfferingAmt | USD | 117.53M | 2026-04-14 | S-1 | 2026-04-17 | 0001193125-26-161516 | |||
| ffd | TtlOffsetAmt | TtlOffsetAmt | USD | 0 | 2026-04-14 | S-1 | 2026-04-17 | 0001193125-26-161516 | |||
| ffd | TtlPrevslyPdAmt | TtlPrevslyPdAmt | USD | 0 | 2026-04-14 | S-1 | 2026-04-17 | 0001193125-26-161516 | |||
| us-gaap | AccountsPayableCurrent | Accounts Payable, Current | USD | 9.10M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 | |
| us-gaap | AccretionAmortizationOfDiscountsAndPremiumsInvestments | Accretion (Amortization) of Discounts and Premiums, Investments | USD | 1.81M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 |
| us-gaap | AccruedLiabilitiesCurrent | Accrued Liabilities, Current | USD | 9.63M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 | |
| us-gaap | AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment | Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | USD | 1.79M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 | |
| us-gaap | AccumulatedDepreciationDepletionAndAmortizationSaleOfPropertyPlantAndEquipment1 | Accumulated Depreciation, Depletion and Amortization, Sale or Disposal of Property, Plant and Equipment | USD | 300,000 | 2026-01-01 | 2026-03-31 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 |
| us-gaap | AdditionalPaidInCapitalCommonStock | Additional Paid in Capital, Common Stock | USD | 557.25M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 | |
| us-gaap | AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation | Share-based Payment Arrangement, Decrease for Tax Withholding Obligation | USD | 1.22M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-093932 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue | APIC, Share-based Payment Arrangement, Increase for Cost Recognition | USD | 12.48M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 |
| us-gaap | AllocatedShareBasedCompensationExpense | Share-based Payment Arrangement, Expense | USD | 12.48M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 |
| us-gaap | AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares | 7.97M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 |
| us-gaap | AssetImpairmentCharges | Asset Impairment Charges | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-093932 |
| us-gaap | Assets | Assets | USD | 278.30M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 | |
| us-gaap | AssetsCurrent | Assets, Current | USD | 174.56M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 | |
| us-gaap | CapitalExpendituresIncurredButNotYetPaid | Capital Expenditures Incurred but Not yet Paid | USD | 26,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 |
| us-gaap | CashAndCashEquivalentsAtCarryingValue | Cash and Cash Equivalents, at Carrying Value | USD | 47.57M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | USD | 48.77M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | USD | 3.29M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 |
| us-gaap | CommonStockCapitalSharesReservedForFutureIssuance | Common Stock, Capital Shares Reserved for Future Issuance | shares | 8.49M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 | |
| us-gaap | CommonStockNoParValue | Common Stock, No Par Value | USD/shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 | |
| us-gaap | CommonStockParOrStatedValuePerShare | Common Stock, Par or Stated Value Per Share | USD/shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 | |
| us-gaap | CommonStockSharesAuthorized | Common Stock, Shares Authorized | shares | 500.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 | |
| us-gaap | CommonStockSharesIssued | Common Stock, Shares, Issued | shares | 36.38M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 | |
| us-gaap | CommonStockSharesOutstanding | Common Stock, Shares, Outstanding | shares | 36.38M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 | |
| us-gaap | CommonStockValue | Common Stock, Value, Issued | USD | 4,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 | |
| us-gaap | ContractWithCustomerLiabilityCurrent | Contract with Customer, Liability, Current | USD | 3.00M | 2024-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-093932 | |
| us-gaap | ConversionOfStockAmountConverted1 | Conversion of Stock, Amount Converted | USD | 257.00M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-093932 |
| us-gaap | ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue | Convertible Preferred Stock, Nonredeemable or Redeemable, Issuer Option, Value | USD | 8.93M | 2024-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-093932 | |
| us-gaap | DebtSecuritiesHeldToMaturityFairValueCurrent | DebtSecuritiesHeldToMaturityFairValueCurrent | USD | 120.68M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 | |
| us-gaap | DebtSecuritiesHeldToMaturityFairValueNoncurrent | DebtSecuritiesHeldToMaturityFairValueNoncurrent | USD | 92.54M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 | |
| us-gaap | DeferredOfferingCosts | Deferred Offering Costs | USD | 2.10M | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-12-11 | 0001193125-25-315972 | |
| us-gaap | DeferredTaxAssetsDeferredIncome | Deferred Tax Assets, Deferred Income | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-093932 | |
| us-gaap | DeferredTaxAssetsGoodwillAndIntangibleAssets | Deferred Tax Assets, Goodwill and Intangible Assets | USD | 5.63M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-093932 | |
| us-gaap | DeferredTaxAssetsGross | Deferred Tax Assets, Gross | USD | 52.81M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-093932 | |
| us-gaap | DeferredTaxAssetsLiabilitiesNet | Deferred Tax Assets, Net | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-093932 | |
| us-gaap | DeferredTaxAssetsNet | Deferred Tax Assets, Net of Valuation Allowance | USD | 52.39M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-093932 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwards | Deferred Tax Assets, Operating Loss Carryforwards | USD | 11.97M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-093932 | |
| us-gaap | DeferredTaxAssetsOther | Deferred Tax Assets, Other | USD | 129,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-093932 | |
| us-gaap | DeferredTaxAssetsTaxCreditCarryforwards | Deferred Tax Assets, Tax Credit Carryforwards | USD | 6.26M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-093932 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost | USD | 525,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-093932 | |
| us-gaap | DeferredTaxAssetsValuationAllowance | Deferred Tax Assets, Valuation Allowance | USD | 52.39M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-093932 | |
| us-gaap | DepreciationAndAmortization | Depreciation, Depletion and Amortization, Nonproduction | USD | 1.44M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 |
| us-gaap | DepreciationDepletionAndAmortization | Depreciation, Depletion and Amortization | USD | 500,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 |
| us-gaap | DividendsCommonStock | Dividends, Common Stock | USD | 1.50M | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-093932 |
| us-gaap | EarningsPerShareBasic | Earnings Per Share, Basic | USD/shares | -2.4 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 |
| us-gaap | EarningsPerShareDiluted | Earnings Per Share, Diluted | USD/shares | -2.4 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 |
| us-gaap | EffectiveIncomeTaxRateContinuingOperations | Effective Income Tax Rate Reconciliation, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-093932 |
| us-gaap | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | pure | 0.21 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-093932 |
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent | pure | -0.193 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-093932 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent | pure | -0.004 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-093932 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent | pure | -0.012 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-093932 |
| us-gaap | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-093932 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxContingencies | Effective Income Tax Rate Reconciliation, Tax Contingency, Percent | pure | -0.007 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-093932 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxCreditsResearch | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent | pure | -0.033 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-093932 |
| us-gaap | FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Issuances | USD | 8.93M | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-093932 |
| us-gaap | FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Period Increase (Decrease) | USD | 8.93M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-093932 |
| us-gaap | FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value | USD | 8.93M | 2024-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-093932 | |
| us-gaap | FederalIncomeTaxExpenseBenefitContinuingOperations | Federal Income Tax Expense (Benefit), Continuing Operations | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-093932 |
| us-gaap | FinanceLeaseInterestExpense | Finance Lease, Interest Expense | USD | 58,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 |
| us-gaap | FinanceLeaseLiability | Finance Lease, Liability | USD | 811,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 | |
| us-gaap | FinanceLeaseLiabilityCurrent | Finance Lease, Liability, Current | USD | 469,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 | |
| us-gaap | FinanceLeaseLiabilityNoncurrent | Finance Lease, Liability, Noncurrent | USD | 342,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 | |
| us-gaap | FinanceLeaseLiabilityPaymentsDue | Finance Lease, Liability, Payment, Due | USD | 906,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 | |
| us-gaap | FinanceLeaseLiabilityPaymentsDueNextTwelveMonths | Finance Lease, Liability, to be Paid, Year One | USD | 433,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 | |
| us-gaap | FinanceLeaseLiabilityPaymentsDueYearThree | Finance Lease, Liability, to be Paid, Year Three | USD | 4,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-093932 | |
| us-gaap | FinanceLeaseLiabilityPaymentsDueYearTwo | Finance Lease, Liability, to be Paid, Year Two | USD | 250,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 | |
| us-gaap | FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear | Finance Lease, Liability, to be Paid, Remainder of Fiscal Year | USD | 162,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 | |
| us-gaap | FinanceLeaseLiabilityUndiscountedExcessAmount | Finance Lease, Liability, Undiscounted Excess Amount | USD | 95,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 | |
| us-gaap | FinanceLeasePrincipalPayments | Finance Lease, Principal Payments | USD | 370,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 |
| us-gaap | FinanceLeaseRightOfUseAsset | Finance Lease, Right-of-Use Asset, after Accumulated Amortization | USD | 600,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 | |
| us-gaap | FinanceLeaseRightOfUseAssetAmortization | Finance Lease, Right-of-Use Asset, Amortization | USD | 370,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 |
| us-gaap | FinanceLeaseWeightedAverageDiscountRatePercent | Finance Lease, Weighted Average Discount Rate, Percent | pure | 0.09 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 | |
| us-gaap | GainLossOnSaleOfPropertyPlantEquipment | Gain (Loss) on Disposition of Property Plant Equipment | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 |
| us-gaap | GeneralAndAdministrativeExpense | General and Administrative Expense | USD | 23.89M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 |
| us-gaap | HeldToMaturitySecurities | Debt Securities, Held-to-maturity | USD | 49.24M | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-12-11 | 0001193125-25-315972 | |
| us-gaap | HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain | Debt Securities, Held-to-maturity, Accumulated Unrecognized Gain | USD | 2,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 | |
| us-gaap | HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss | Debt Securities, Held-to-maturity, Accumulated Unrecognized Loss | USD | 393,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 | |
| us-gaap | HeldToMaturitySecuritiesCurrent | Debt Securities, Held-to-maturity, Current | USD | 121.07M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 | |
| us-gaap | HeldToMaturitySecuritiesFairValue | Debt Securities, Held-to-maturity, Fair Value | USD | 49.24M | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-12-11 | 0001193125-25-315972 | |
| us-gaap | HeldToMaturitySecuritiesNoncurrent | Debt Securities, Held-to-maturity, Noncurrent | USD | 93.61M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 | |
| us-gaap | ImpairmentOfLongLivedAssetsHeldForUse | Impairment of Long-Lived Assets Held-for-use | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-093932 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic | Income (Loss) from Continuing Operations before Income Taxes, Domestic | USD | -68.87M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-093932 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | USD | -68.87M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-093932 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign | Income (Loss) from Continuing Operations before Income Taxes, Foreign | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-093932 |
| us-gaap | IncomeTaxExpenseBenefit | Income Tax Expense (Benefit) | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 |
| us-gaap | IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount | USD | 13.31M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-093932 |
| us-gaap | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount | USD | -14.46M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-093932 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseOther | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount | USD | 276,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-093932 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount | USD | 837,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-093932 |
| us-gaap | IncomeTaxReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-093932 |
| us-gaap | IncomeTaxReconciliationTaxContingencies | Effective Income Tax Rate Reconciliation, Tax Contingency, Amount | USD | 458,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-093932 |
| us-gaap | IncomeTaxReconciliationTaxCreditsResearch | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount | USD | 2.29M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-093932 |
| us-gaap | IncreaseDecreaseInAccountsPayable | Increase (Decrease) in Accounts Payable | USD | 1.32M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 |
| us-gaap | IncreaseDecreaseInAccruedLiabilities | Increase (Decrease) in Accrued Liabilities | USD | 87,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 |
| us-gaap | IncreaseDecreaseInContractWithCustomerLiability | Increase (Decrease) in Contract with Customer, Liability | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 |
| us-gaap | IncreaseDecreaseInOperatingLeaseLiability | IncreaseDecreaseInOperatingLeaseLiability | USD | -833,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 |
| us-gaap | IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets | Increase (Decrease) in Prepaid Expense and Other Assets | USD | 1.59M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 |
| us-gaap | InterestPaidNet | Interest Paid, Excluding Capitalized Interest, Operating Activities | USD | 4,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 |
| us-gaap | InterestReceivable | Interest Receivable | USD | 1.90M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 | |
| us-gaap | InvestmentIncomeInterest | Investment Income, Interest | USD | 7.41M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 |
| us-gaap | Investments | Investments | USD | 214.68M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 | |
| us-gaap | InvestmentsFairValueDisclosure | Investments, Fair Value Disclosure | USD | 213.22M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 | |
| us-gaap | LeaseCost | Lease, Cost | USD | 2.87M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDue | Lessee, Operating Lease, Liability, to be Paid | USD | 9.06M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths | Lessee, Operating Lease, Liability, to be Paid, Year One | USD | 1.89M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearThree | Lessee, Operating Lease, Liability, to be Paid, Year Three | USD | 394,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-093932 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearTwo | Lessee, Operating Lease, Liability, to be Paid, Year Two | USD | 1.94M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear | Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year | USD | 464,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 | |
| us-gaap | LesseeOperatingLeaseLiabilityUndiscountedExcessAmount | Lessee, Operating Lease, Liability, Undiscounted Excess Amount | USD | 1.68M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 | |
| us-gaap | Liabilities | Liabilities | USD | 26.93M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 | |
| us-gaap | LiabilitiesAndStockholdersEquity | Liabilities and Equity | USD | 278.30M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 | |
| us-gaap | LiabilitiesCurrent | Liabilities, Current | USD | 20.48M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 | |
| us-gaap | LongTermInvestments | Long-term Investments | USD | 93.61M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 | |
| us-gaap | NetCashProvidedByUsedInFinancingActivities | Net Cash Provided by (Used in) Financing Activities | USD | 117.74M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 |
| us-gaap | NetCashProvidedByUsedInInvestingActivities | Net Cash Provided by (Used in) Investing Activities | USD | -40.74M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 |
| us-gaap | NetCashProvidedByUsedInOperatingActivities | Net Cash Provided by (Used in) Operating Activities | USD | -73.70M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 |
| us-gaap | NetIncomeLoss | Net Income (Loss) Attributable to Parent | USD | -84.80M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 |
| us-gaap | NetIncomeLossAvailableToCommonStockholdersBasic | Net Income (Loss) Available to Common Stockholders, Basic | USD | -68.87M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-093932 |
| us-gaap | NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1 | Noncash or Part Noncash Acquisition, Value of Assets Acquired | USD | 652,000 | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-06 | 0001193125-26-337984 |
| us-gaap | NumberOfOperatingSegments | Number of Operating Segments | Segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 |
| us-gaap | OperatingExpenses | Operating Expenses | USD | 92.18M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 |
| us-gaap | OperatingIncomeLoss | Operating Income (Loss) | USD | -92.18M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 |
| us-gaap | OperatingLeaseCost | Operating Lease, Cost | USD | 1.22M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 |
| us-gaap | OperatingLeaseLiability | Operating Lease, Liability | USD | 7.38M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 | |
| us-gaap | OperatingLeaseLiabilityCurrent | Operating Lease, Liability, Current | USD | 1.28M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 | |
| us-gaap | OperatingLeaseLiabilityNoncurrent | Operating Lease, Liability, Noncurrent | USD | 6.11M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 | |
| us-gaap | OperatingLeasePayments | Operating Lease, Payments | USD | 1.20M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 |
| us-gaap | OperatingLeaseRightOfUseAsset | Operating Lease, Right-of-Use Asset | USD | 7.25M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 | |
| us-gaap | OperatingLeaseWeightedAverageDiscountRatePercent | Operating Lease, Weighted Average Discount Rate, Percent | pure | 0.089 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 | |
| us-gaap | OtherAccruedLiabilitiesCurrent | Other Accrued Liabilities, Current | USD | 410,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 | |
| us-gaap | OtherAssetsNoncurrent | Other Assets, Noncurrent | USD | 42,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 | |
| us-gaap | OtherLiabilitiesCurrent | Other Liabilities, Current | USD | 469,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 | |
| us-gaap | OtherLiabilitiesNoncurrent | Other Liabilities, Noncurrent | USD | 261,000 | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-12-11 | 0001193125-25-315972 | |
| us-gaap | OtherNonoperatingExpense | Other Nonoperating Expense | USD | 35,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 |
| us-gaap | OtherNonoperatingIncomeExpense | Other Nonoperating Income (Expense) | USD | 7.38M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 |
| us-gaap | OtherResearchAndDevelopmentExpense | Other Research and Development Expense | USD | 15.69M | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-06 | 0001193125-26-337984 |
| us-gaap | PaymentsOfDebtIssuanceCosts | Payments of Debt Issuance Costs | USD | 1.10M | 2025-01-01 | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-12-11 | 0001193125-25-315972 |
| us-gaap | PaymentsOfFinancingCosts | Payments of Financing Costs | USD | 874,000 | 2025-01-01 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 |
| us-gaap | PaymentsRelatedToTaxWithholdingForShareBasedCompensation | Payment, Tax Withholding, Share-based Payment Arrangement | USD | 1.22M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-093932 |
| us-gaap | PaymentsToAcquireInvestments | Payments to Acquire Investments | USD | 173.94M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 |
| us-gaap | PaymentsToAcquirePropertyPlantAndEquipment | Payments to Acquire Property, Plant, and Equipment | USD | 499,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 |
| us-gaap | PaymentsToAcquireShortTermInvestments | Payments to Acquire Short-term Investments | USD | 38.77M | 2025-01-01 | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-12-11 | 0001193125-25-315972 |
| us-gaap | PreferredStockDividendRatePercentage | Preferred Stock, Dividend Rate, Percentage | pure | 0.08 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-093932 |
| us-gaap | PrepaidExpenseAndOtherAssetsCurrent | Prepaid Expense and Other Assets, Current | USD | 5.92M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 | |
| us-gaap | ProceedsFromIssuanceInitialPublicOffering | Proceeds from Issuance Initial Public Offering | USD | 157.28M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-093932 |
| us-gaap | ProceedsFromIssuanceOfCommonStock | Proceeds from Issuance of Common Stock | USD | 117.10M | 2026-02-01 | 2026-02-28 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 |
| us-gaap | ProceedsFromIssuanceOfConvertiblePreferredStock | Proceeds from Issuance of Convertible Preferred Stock | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 |
| us-gaap | ProceedsFromIssuanceOfPrivatePlacement | Proceeds from Issuance of Private Placement | USD | 117.06M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 |
| us-gaap | ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments | Proceeds from Maturities, Prepayments and Calls of Short-term Investments | USD | 46.50M | 2025-01-01 | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-12-11 | 0001193125-25-315972 |
| us-gaap | ProceedsFromSaleMaturityAndCollectionsOfInvestments | Proceeds from Sale, Maturity and Collection of Investments | USD | 133.70M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 |
| us-gaap | ProceedsFromStockOptionsExercised | Proceeds from Stock Options Exercised | USD | 977,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 |
| us-gaap | ProceedsFromStockPlans | Proceeds from Stock Plans | USD | 67,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 |
| us-gaap | ProfitLoss | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | USD | -84.80M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 |
| us-gaap | PropertyPlantAndEquipmentGross | Property, Plant and Equipment, Gross | USD | 3.42M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 | |
| us-gaap | PropertyPlantAndEquipmentNet | Property, Plant and Equipment, Net | USD | 1.63M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 | |
| us-gaap | RepaymentsOfDebt | Repayments of Debt | USD | 158,000 | 2025-01-01 | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-12-11 | 0001193125-25-315972 |
| us-gaap | ResearchAndDevelopmentExpense | Research and Development Expense | USD | 68.28M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 |
| us-gaap | RestrictedCash | Restricted Cash | USD | 1.20M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 | |
| us-gaap | RestrictedCashNoncurrent | Restricted Cash, Noncurrent | USD | 1.20M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 | |
| us-gaap | RetainedEarningsAccumulatedDeficit | Retained Earnings (Accumulated Deficit) | USD | -305.89M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 | |
| us-gaap | RevenueFromContractWithCustomerExcludingAssessedTax | Revenue from Contract with Customer, Excluding Assessed Tax | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 |
| us-gaap | RevenueFromContractWithCustomerIncludingAssessedTax | Revenue from Contract with Customer, Including Assessed Tax | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 |
| us-gaap | RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability | Right-of-Use Asset Obtained in Exchange for Finance Lease Liability | USD | 652,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 |
| us-gaap | RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability | USD | 6.68M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 |
| us-gaap | SaleOfStockPricePerShare | Sale of Stock, Price Per Share | USD/shares | 27.88 | 2026-02-28 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 | |
| us-gaap | ShareBasedCompensation | Share-based Payment Arrangement, Noncash Expense | USD | 12.48M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate | pure | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum | pure | 0.887 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum | pure | 0.816 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate | pure | 0.041 | 2025-01-01 | 2025-03-31 | 2026 | Q1 | 10-Q | 2026-05-07 | 0001193125-26-211963 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum | pure | 0.051 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum | pure | 0.038 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value | USD | 12.65M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number | shares | 2.49M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price | USD/shares | 3.19 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value | USD | 6.31M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period | shares | 276,982 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | shares | 1.23M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value | USD/shares | 2.3 | 2025-01-01 | 2025-03-31 | 2026 | Q1 | 10-Q | 2026-05-07 | 0001193125-26-211963 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares | Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares | shares | 5,503 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-093932 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value | USD | 16.85M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | shares | 7.19M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price | USD/shares | 11.85 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value | USD | 16.85M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price | USD/shares | 11.85 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number | shares | 7.19M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 | |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares | shares | 13,552 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-093932 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price | USD/shares | 2.72 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price | USD/shares | 15.29 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | USD/shares | 25.04 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 |
| us-gaap | ShortTermInvestments | Short-term Investments | USD | 121.07M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 | |
| us-gaap | ShortTermLeaseCost | Short-term Lease, Cost | USD | 771,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 |
| us-gaap | StateAndLocalIncomeTaxExpenseBenefitContinuingOperations | State and Local Income Tax Expense (Benefit), Continuing Operations | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-093932 |
| us-gaap | StockholdersEquity | Stockholders' Equity Attributable to Parent | USD | 251.37M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 | |
| us-gaap | StockholdersEquityNoteStockSplitConversionRatio1 | Stockholders' Equity Note, Stock Split, Conversion Ratio | pure | 0.117 | 2025-10-17 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-093932 | |
| us-gaap | StockIssuedDuringPeriodSharesNewIssues | Stock Issued During Period, Shares, New Issues | shares | 4.49M | 2026-02-01 | 2026-02-28 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 |
| us-gaap | StockIssuedDuringPeriodSharesStockOptionsExercised | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | shares | 355,016 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 |
| us-gaap | StockIssuedDuringPeriodValueConversionOfConvertibleSecurities | Stock Issued During Period, Value, Conversion of Convertible Securities | USD | 257.00M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-093932 |
| us-gaap | StockIssuedDuringPeriodValueEmployeeStockPurchasePlan | Stock Issued During Period, Value, Employee Stock Purchase Plan | USD | 67,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 |
| us-gaap | StockIssuedDuringPeriodValueNewIssues | Stock Issued During Period, Value, New Issues | USD | 117.06M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 |
| us-gaap | StockIssuedDuringPeriodValueStockOptionsExercised | Stock Issued During Period, Value, Stock Options Exercised | USD | 977,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 |
| us-gaap | TemporaryEquityCarryingAmountAttributableToParent | Temporary Equity, Carrying Amount, Attributable to Parent | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-093932 | |
| us-gaap | TemporaryEquityLiquidationPreference | Temporary Equity, Liquidation Preference | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-093932 | |
| us-gaap | TemporaryEquityParOrStatedValuePerShare | Temporary Equity, Par or Stated Value Per Share | USD/shares | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-093932 | |
| us-gaap | TemporaryEquitySharesAuthorized | Temporary Equity, Shares Authorized | shares | 10.00M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-093932 | |
| us-gaap | TemporaryEquitySharesIssued | Temporary Equity, Shares Issued | shares | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-093932 | |
| us-gaap | TemporaryEquitySharesOutstanding | Temporary Equity, Shares Outstanding | shares | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-093932 | |
| us-gaap | UnrecognizedTaxBenefits | Unrecognized Tax Benefits | USD | 1.60M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-093932 | |
| us-gaap | UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions | Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions | USD | 75,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-093932 |
| us-gaap | UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense | Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-093932 |
| us-gaap | UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions | Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions | USD | 608,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-093932 |
| us-gaap | ValuationAllowanceDeferredTaxAssetChangeInAmount | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount | USD | 13.57M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-093932 |
| us-gaap | VariableLeaseCost | Variable Lease, Cost | USD | 447,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 |
| us-gaap | WeightedAverageNumberDilutedSharesOutstandingAdjustment | Weighted Average Number Diluted Shares Outstanding Adjustment | shares | 35.39M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 |
| us-gaap | WeightedAverageNumberOfDilutedSharesOutstanding | Weighted Average Number of Shares Outstanding, Diluted | shares | 35.39M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 |
| us-gaap | WeightedAverageNumberOfSharesOutstandingBasic | Weighted Average Number of Shares Outstanding, Basic | shares | 35.39M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 |
| us-gaap | WorkersCompensationLiabilityCurrent | Workers' Compensation Liability, Current | USD | 3.48M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458385 |